4.7 Article

Somatic selection distinguishes oncogenes and tumor suppressor genes

Journal

BIOINFORMATICS
Volume 36, Issue 6, Pages 1712-1717

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btz851

Keywords

-

Funding

  1. National Institutes of Health [LM012487, U54CA217376]
  2. Flinn Foundation [2088]
  3. Mayo Clinic
  4. Arizona State University Alliance for Health Care Seed Grant

Ask authors/readers for more resources

Motivation: Functions of cancer driver genes vary substantially across tissues and organs. Distinguishing passenger genes, oncogenes (OGs) and tumor-suppressor genes (TSGs) for each cancer type is critical for understanding tumor biology and identifying clinically actionable targets. Although many computational tools are available to predict putative cancer driver genes, resources for context-aware classifications of OGs and TSGs are limited. Results: We show that the direction and magnitude of somatic selection of protein-coding mutations are significantly different for passenger genes, OGs and TSGs. Based on these patterns, we develop a new method (genes under selection in tumors) to discover OGs and TSGs in a cancer-type specific manner. Genes under selection in tumors shows a high accuracy (92%) when evaluated via strict cross-validations. Its application to 10 172 tumor exomes found known and novel cancer drivers with high tissue-specificities. In 11 out of 13 OGs shared among multiple cancer types, we found functional domains selectively engaged in different cancers, suggesting differences in disease mechanisms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available